From: Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis
 | Type of reaction | ||||
---|---|---|---|---|---|
TYPE n(%) | Systemic | Local | Systemic and Local | ||
Not Reported | 27 | (41.54) | 21 | 4 | 2 |
Hexavalent | 9 | (13.85) | 7 | 2 | Â |
DTaP, MMR | 8 | (12.31) | 1 | 5 | 2 |
MMR | 5 | (7.69) | 2 | 1 | 2 |
MMR, MEN C | 3 | (4.62) | 3 | Â | Â |
DTaP, IPV | 3 | (4.62) | Â | 2 | 1 |
HPV | 2 | (3.08) | 2 | Â | Â |
PCV | 2 | (3.08) | 1 | 1 | Â |
PNEUMOVAX 23 | 2 | (3.08) | Â | Â | 2 |
BCG | 1 | (1.54) | Â | 1 | Â |
Hepa B | 1 | (1.54) | 1 | Â | Â |
MEN C | 1 | (1.54) | Â | 1 | Â |
MMR, DTP, IPV | 1 | (1.54) | Â | 1 | Â |